[Pharmacological actions of N-ethylamalemide (NEM). 2. Inflammatory and hyperglycemic properties of NEM].
D000818:Animals; D001201:Ascites / Q000139:chemically induced; D001786:Blood Glucose / Q000378:metabolism; D002199:Capillary Permeability / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D004487:Edema / Q000139:chemically induced; D004837:Epinephrine / Q000494:pharmacology; D005033:Ethylmaleimide / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D006400:Hematocrit; D006943:Hyperglycemia / Q000139:chemically induced*; D007249:Inflammation / Q000139:chemically induced*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007328:Insulin / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism; D007958:Leukocyte Count; D008099:Liver / Q000098:blood supply / Q000187:drug effects; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D051381:Rats
D001786:Blood Glucose; D002395:Catecholamines; D007328:Insulin; D007773:Lactates; D005033:Ethylmaleimide; D004837:Epinephrine